EMCURE PHARMACEUTICALS
Back to Income Statement
|
EMCURE PHARMACEUTICALS Last 5 Year Profit After Tax History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Profit After Tax | ₹707 Cr | ₹528 Cr | ₹562 Cr | ₹703 Cr | ₹419 Cr |
What is the latest Profit After Tax of EMCURE PHARMACEUTICALS ?
| Year | Profit After Tax |
|---|---|
| Mar2025 | ₹707 Cr |
| Mar2024 | ₹528 Cr |
| Mar2023 | ₹562 Cr |
| Mar2022 | ₹703 Cr |
| Mar2021 | ₹419 Cr |
How is Profit After Tax of EMCURE PHARMACEUTICALS Trending?
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2025 | ₹707 Cr | 34.10 | |
| Mar2024 | ₹528 Cr | -6.10 | |
| Mar2023 | ₹562 Cr | -20.03 | |
| Mar2022 | ₹703 Cr | 67.84 | |
| Mar2021 | ₹419 Cr | - | |
Compare Profit After Tax of peers of EMCURE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EMCURE PHARMACEUTICALS | ₹30,219.4 Cr | 8.4% | 11.1% | 53.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹430,645.0 Cr | 2.9% | 3.6% | 0.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,625.0 Cr | 0.6% | -4.5% | 3.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹145,415.0 Cr | 2.1% | -0.4% | 31.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,664.0 Cr | 2.2% | -0.4% | 6.2% | Stock Analytics | |
| CIPLA | ₹100,480.0 Cr | 0.4% | -6.2% | -19.4% | Stock Analytics | |
EMCURE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EMCURE PHARMACEUTICALS | 8.4% |
11.1% |
53.8% |
| SENSEX | -1.9% |
-9.1% |
-0.2% |
You may also like the below Video Courses